论文部分内容阅读
奥立克斯生物制药公司的破伤风抗毒素拮抗剂进入临床试验根据奥立克斯（Ａｌｌｅｌｉｘ）生物制药公司１９９３年的年度报告，该公司的抗ＨＩＶ治疗药ＡＬＸ４Ｏ－４Ｃ在加拿大已进入临床试验。４ＬＸ４０－４Ｃ是一种合成肽破伤风抗毒素拮抗剂。它是通过病毒蛋白，破伤风...
Oliver Biotech’s Tetanus Antitoxin Antagonists Enter Clinical Trial According to the 1993 annual report of Allelix Biopharmaceuticals, the company’s anti-HIV therapeutic ALX4O-4C has entered clinical trials in Canada. 4LX40-4C is a synthetic peptide tetanus antitoxin antagonist. It is through viral proteins, tetanus ...